Movatterモバイル変換


[0]ホーム

URL:


Prijeđi na sadržaj
Wikipedija
Pretraga

Spirapril

Izvor: Wikipedija
Spirapril
(IUPAC) ime
(8S)-7-[(2S)-2- {[(2S)-1-etoksi-1-okso-4-fenilbutan-2-il]amino}propanoil]-1,4-ditia-7-azaspiro[4.4]nonan-8-karboksilna kiselina
Klinički podaci
AHFS/Drugs.comInternacionalno ime leka
Identifikatori
CAS broj83647-97-6
ATC kodC09AA11
PubChem[1][2]5311447
DrugBankDB01348
ChemSpider[3]4470933
UNII96U2K78I3V DaY
KEGG[4]D08529 DaY
ChEMBL[5]CHEMBL431 DaY
Hemijski podaci
FormulaC22H30N2O5S2 
Mol. masa466,616 g/mol
SMILESeMolekuli &PubHem
InChI
InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1 DaY
Key: HRWCVUIFMSZDJS-SZMVWBNQSA-N DaY
Farmakokinetički podaci
Bioraspoloživost50%
Metabolizamkonvertuje se u spiraprilat
Poluvreme eliminacije30 do 35 sati
IzlučivanjeHepatički irenalno
Farmakoinformacioni podaci
Trudnoća?
Pravni status Prescription only
Način primeneOralno

Spirapril hidrohlorid (Renormax) jeACE inhibitorantihipertenzivni lek koji se koristi u tretmanuhipertenzije. On pripada dikarboksilnoj grupi ACE inhibitora.

Poput mnogih ACE inhibitora, ovaj lek jeprolek koji se konvertuje do aktivnog metabolitaspiraprilata nakon oralne administracije. Za razliku od drugih članova grupe, on se eliminiše renalnim i hepatičkim putem, te je podesniji za primenu kod pacijenata sa renalnim oštećenjima.[6][7]

Osobine

[uredi |uredi kod]
OsobinaVrednost
Broj akceptora vodonika8
Broj donora vodonika2
Broj rotacionih veza10
Particioni koeficijent[8] (ALogP)0,3
Rastvorljivost[9] (logS, log(mol/L))-5,4
Polarna površina[10] (PSA,Å2)146,5

Reference

[uredi |uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Shohat J, Wittenberg C, Erman A, Rosenfeld J, Boner G (1999). „Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.”. Scand J Urol Nephrol 33 (1): 57–62. DOI:10.1080/003655999750016294. PMID 10100366. 
  7. Noble S, Sorkin E (1995). „Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.”. Drugs 49 (5): 750–66. PMID 7601014. 
  8. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  9. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  10. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

[uredi |uredi kod]

Vanjske veze

[uredi |uredi kod]
Portal Medicina
Portal Hemija
Spirapril naWikimedijinoj ostavi
Antihipertenzivi: Lekovi koji deluju narenin-angiotenzin sistem (C09)
AKE inhibitori/
("-pril")
AIIRAi/
("-sartan")
Renin inhibitori/
("-kiren")
Izvor:https://sh.wikipedia.org/w/index.php?title=Spirapril&oldid=42285001
Kategorije:

[8]ページ先頭

©2009-2025 Movatter.jp